Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA). 1998

H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
Institute of Biology, University of Iceland, Reykjavik, Iceland. halldort@rhi.hi.is

Nucleoside and nucleotide analogues, which are inhibitors of human immunodeficiency virus reverse transcriptase, are highly active inhibitors of visna virus replication in cell cultures. One such analogue, the acyclic nucleoside phosphonate PMEA, has also been found to have a prophylactic effect on visna virus infection in lambs. In the present study, lambs were injected subcutaneously with 10 mg/kg PMEA three times a week starting 4 weeks after inoculation with visna virus, when brain infection had been established. After 3 weeks of treatment there was a reduction in the amount of virus isolated from blood cells of PMEA-treated lambs compared to controls and during the remaining 7 months of drug treatment there was significantly less virus isolated from the blood cells of treated lambs than of controls. Antibody response against visna virus was also slower in the treated than in the untreated control group. On the other hand, there was no difference in the amount of virus isolated from various organs of the two groups and the severity of CNS lesions in sheep treated with PMEA for 8 months was comparable to that found in untreated controls, even though PMEA reached concentrations in the cerebrospinal fluid which were well in excess of the EC50 value of the drug for visna virus.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012327 RNA Virus Infections Diseases caused by RNA VIRUSES. Infections, RNA Virus,Infection, RNA Virus,RNA Virus Infection,Virus Infection, RNA,Virus Infections, RNA

Related Publications

H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
December 1998, Antimicrobial agents and chemotherapy,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
February 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
May 1998, International journal of cancer,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
March 1998, Biochimica et biophysica acta,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
July 1991, Antiviral research,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
January 1996, Pharmacy world & science : PWS,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
June 1993, Antiviral research,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
January 1994, Advances in experimental medicine and biology,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
May 1998, Antimicrobial agents and chemotherapy,
H Thormar, and G Georgsson, and E Gunnarsson, and L Naesens, and S Torsteinsdóttir, and J Balzarini, and E De Clercq
July 1991, Antiviral research,
Copied contents to your clipboard!